Moench, RomanaGrimmig, TanjaKannen, ViniciusTripathi, SudiptaFaber, MarcMoll, Eva-MariaChandraker, AnilLissner, ReinhardGermer, Christoph-ThomasWaaga-Gasser, Ana MariaGasser, Martin2019-01-142019-01-142016-09-08Moench, R, Grimmig, T, Kannen, V, Tripathi, S, Faber, M, Moll, E-M, Chandraker, A, Lissner, R, Germer, C-T, Waaga-Gasser, A M & Gasser, M 2016, 'Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer', Oncotarget, vol. 7, no. 42, pp. 68749-68767. https://doi.org/10.18632/oncotarget.11899PubMedCentral: PMC5356587http://hdl.handle.net/2164/11776We thank Mrs. Nadine Rhodes, Mrs. Sabine Mueller-Morath, and Mrs. Mariola Dragan for their excellent technical assistance as well as Mrs. Ingrid Strauss and Mrs. Ulrike Faber. We also thank Mrs. and Mr. Dr. Sommer for their expertise in the oxygen measurement.1911022792engSDG 3 - Good Health and Well-beingPDGFcolorectal cancerPI3K/Akt/mTORMAPK pathwayglucose metabolismRC0254 Neoplasms. Tumors. Oncology (including Cancer)RC0254Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancerJournal article10.18632/oncotarget.11899742